OVAMIR
Live / Applied — Statement of use — final refusal mailed (as of 29 Dec 2025)
What this means for you
Not registered yet, but its 16 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97594340
- Mark type
- Stylized text
- Filed
- 16 Sept 2022
- Published for opposition
- 20 Jun 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- AptamiR Therapeutics, Inc., NAPLES, FL, US
- AptamiR Therapeutics, Inc., NAPLES, FL, US
Prosecution history
- 29 Dec 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 29 Dec 2025 — FINAL REFUSAL E-MAILED
- 29 Dec 2025 — SU - FINAL REFUSAL - WRITTEN
- 19 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Nov 2025 — ASSIGNED TO LIE
- 05 Nov 2025 — NOTICE OF REVIVAL - E-MAILED
- 05 Nov 2025 — PETITION GRANTED - RESPONSE RECEIVED
- 18 Sept 2025 — TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
- 18 Sept 2025 — INCOMPLETE PETITION NOTICE MAILED
- 27 Aug 2025 — TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
- 20 Aug 2025 — INCOMPLETE PETITION NOTICE MAILED
- 18 Aug 2025 — ASSIGNED TO PETITION STAFF
- 07 Jul 2025 — TEAS PETITION TO REVIVE RECEIVED
- 07 Jul 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND